A marriage of formal methods and LLMs seeks to harness the strengths of both.

I'm sorry NixOS, I've failed you.

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

RXRX has reported updated data from its ELUCIDATE and TUPELO trials, but the stock has failed to mount a sustained rally. The ELUCIDATE update provides just an additional 10 patients of data treated ...

There are many types of errors in Python. No matter where you are in your Python journey, you've most likely faced one or more of these errors. For some, it might be easy to know what's wrong in your ...

AI agents are powerful, but without a strong control plane and hard guardrails, they’re just one bad decision away from chaos.

An earlier headline incorrectly described Jeffrey Sherman as having received an injection that inspired his father to write the Disney song "A Spoonful of Sugar." Sherman did not receive an injection ...

Explaining the policies and processes that define our journalism. “The Times’s primary responsibility is to give readers accurate information, and our readers trust us to do that. By acknowledging our ...

Finding the right book can make a big difference, especially when you’re just starting out or trying to get better. We’ve ...